Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20096125 | 1.00 | PKM (0.38) | PKMALDH1A1OPRM1JAK3KDM4E | |
| SCHEMBL12212559 | 1.00 | PKM (0.38) | PKMALDH1A1OPRM1JAK3KDM4E | |
| SCHEMBL22970027 | 1.00 | PKM (0.38) | PKMALDH1A1OPRM1JAK3KDM4E | |
| SCHEMBL14851697 | 0.95 | OPRM1 (0.41) | PKMALDH1A1OPRM1JAK3KDM4E | |
| SCHEMBL14851703 | 0.95 | OPRM1 (0.41) | PKMALDH1A1OPRM1JAK3KDM4E | |
| SCHEMBL13566523 | 0.95 | OPRM1 (0.41) | PKMALDH1A1OPRM1JAK3KDM4E | |
| SCHEMBL2632502 | 0.95 | OPRM1 (0.41) | PKMALDH1A1OPRM1JAK3KDM4E | |
| SCHEMBL22967662 | 0.84 | — | — | |
| SCHEMBL24227079 | 0.79 | PKM (0.39) | PKMALDH1A1OPRM1 | |
| SCHEMBL20063375 | 0.79 | PKM (0.39) | PKMALDH1A1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2734521-B1 | TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS AND USE THEREOF AS C5A RECEPTOR MODULATORS | NOVARTIS AG (CH) | 2017-05-10 | — | — | EP | disclosed |